Results 191 to 200 of about 479,340 (207)

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Hakan SentÜrk, Yilmaz Cakaloglu   +2 more
exaly  

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Lancet, The, 2013
Patrick Marcellin, Edward Gane, Maria Buti   +2 more
exaly  

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Lancet, The, 2015
David Roth, David R Nelson, Annette Bruchfeld   +2 more
exaly  

Viral Hepatitis: Chronic Hepatitis B

2018
DAL, TUBA, KÖSE, ŞÜKRAN
openaire   +5 more sources

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Lancet, The, 1997
T Poynard, Pierre Bedossa
exaly  

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Lancet, The, 1998
Anders Sönnerborg, Ola Weiland
exaly  

Treatment of Chronic Hepatitis B and Chronic Hepatitis C

Reviews in Medical Virology, 1996
openaire   +2 more sources

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Lancet, The, 2019
Fabrice Carrat, Hélène Fontaine, Christophe Hézode   +2 more
exaly  

MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

Lancet, The, 1989
Michael J Mcgarvey, Peter Karayiannis
exaly  

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

Lancet, The, 1993
exaly